The Diabetes-Neuropathy Connection
Diabetic neuropathy is one of the most common complications of diabetes, affecting up to 50% of all diabetes patients. Prolonged exposure to high blood sugar levels damages peripheral nerves throughout the body, with the legs and feet being the first and most severely affected areas.
At New Promise Neuropathy, we treat diabetic neuropathy with Combined Electrochemical Therapy (CET) using an FDA-cleared device which has improvements over the older Sanexas device and is a non-surgical, in-office treatment that targets nerve damage at its source.
How Diabetes Damages Nerves
Consistently elevated blood sugar creates a toxic environment for peripheral nerves. Over time, high glucose levels:
- Damage the tiny blood vessels that supply nutrients to nerve fibers
- Cause inflammation that compresses and injures nerves
- Disrupt the myelin sheath that insulates and protects nerve cells
- Impair the nerve cell's ability to transmit signals properly
The result is progressive nerve dysfunction that produces pain, numbness, tingling, and muscle weakness — symptoms that worsen without intervention.
Types of Diabetic Neuropathy
- Peripheral Neuropathy: The most common form, affecting the feet, legs, hands, and arms with pain, numbness, and tingling.
- Autonomic Neuropathy: Affects nerves controlling internal organs, causing digestive issues, blood pressure changes, and bladder problems.
- Proximal Neuropathy: Causes weakness and pain in the thighs, hips, or buttocks.
- Mononeuropathy: Damage to a single specific nerve, often causing sudden weakness or pain.
Why CET Is Ideal for Diabetic Neuropathy
Combined Electrochemical Therapy addresses the unique challenges of diabetic neuropathy through a targeted, two-part approach.
Electronic Signal Treatment (EST)
Our device delivers Electronic Signal Treatment — precisely calibrated electrical signals at therapeutic frequencies that:
- Stimulate damaged diabetic nerve fibers to restore signal transmission
- Enhance communication between nerve cells and synapses
- Promote nerve fiber regeneration even in the presence of ongoing metabolic stress
- Improve blood flow to the extremities, counteracting the vascular damage caused by diabetes
Regional Nerve Blocks
Targeted nerve blocks reduce the inflammation that diabetes creates around peripheral nerves. This provides immediate pain relief while establishing the conditions necessary for long-term nerve healing.
Benefits for Diabetic Patients
Patients with diabetic neuropathy who undergo CET at New Promise Neuropathy consistently report:
- Reduced burning and tingling pain in the feet and legs
- Improved sensation where numbness previously prevented feeling
- Better balance and reduced fall risk
- Improved sleep as nighttime pain decreases
- Enhanced daily function and quality of life
Why Choose New Promise Neuropathy
Non-Surgical and Safe for Diabetic Patients
CET requires no surgery, no anesthesia, and no downtime. This is especially important for diabetic patients, who face higher risks from surgical procedures and slower wound healing.
FDA-Cleared Technology
Our device is FDA-cleared for the treatment of peripheral neuropathy, providing a safe and clinically validated option for diabetic patients.
Convenient DFW Locations, and Adding Locations in the Houston Area
We have clinics across DFW including Arlington, Frisco, Fort Worth, Denton, Las Colinas, Tyler, Weatherford, Sherman, Colleyville, and Burleson — with clinics open or opening soon in Spring, TX and Missouri City, TX.
Do Not Let Diabetic Neuropathy Progress
Early intervention is critical for diabetic neuropathy. The sooner CET treatment begins, the greater the opportunity for nerve recovery and symptom improvement.
Schedule your appointment at New Promise Neuropathy and start your journey toward relief from diabetic nerve pain and numbness.
